Sun Pharma share price closes at ₹1,809; stock slips 0.42%
Anupama VM
- 0 min read
Last Updated: 1st October 2026 - 09:15 pm
Key Takeaways:
- Sun Pharma closed at ₹1,809 after a 0.42% decline.
- The closing price moved just below the 200-day DMA of ₹1,826.40.
- Six-month and one-year returns remained positive, with the one-year figure at 14.30%.
Sun Pharma share price closed October 1 at ₹1,809, down 0.42%. The closing price remained below each of the main moving averages displayed on the individual stock page.
The 50-day DMA stood at ₹1,883.30 and the 100-day DMA at ₹1,868.90. The 200-day DMA was lower at ₹1,826.40.
The October 1 close sat only about ₹17 below the 200-day average but more than ₹74 beneath the 50-day measure.
The 52-week range extended from ₹1,584 to ₹2,047. At ₹1,809, Sun Pharma stood roughly ₹225 above the annual low and ₹238 below the high, placing it close to the middle of the range.
One-month performance was -5.39%, while the three-month return was -3.10%. Six-month performance turned positive at 1.28%, and the one-year return was considerably stronger at 14.30%.
Market capitalisation stood around ₹4.36 lakh crore. The closing price was closest to the 200-day moving average among the three DMA references.
October 1 itself was a relatively mild negative session. The stock’s longer one-year performance remained positive even though the one- and three-month readings were below zero.
At ₹1,809, Sun Pharma was also almost equally distant from its 52-week high and low.
The session therefore ended with a slight decline, a close just below the 200-day DMA and a return profile that improved progressively from negative shorter periods to positive six- and 12-month performance.
Frequently Asked Questions
What was Sun Pharma’s closing price on October 1?
How close was Sun Pharma to its 200-day DMA?
What was Sun Pharma’s one-year return?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.